Funding Opportunity: Canadian 2019 Novel Coronavirus (2019-nCoV) Rapid Research
February 14, 2020
We are pleased to inform you that Genome Canada will be partnering with the Canadian Institutes of Health Research (CIHR) on their recent funding opportunity “Canadian 2019 Novel Coronavirus (2019-nCoV) Rapid Research Funding Opportunity.”
This funding opportunity is part of Government of Canada's global effort to address the public health challenges of the novel coronavirus (2019-nCoV) outbreak. We felt that coordinating our efforts with the granting councils would be the fastest and most effective way to have an impact with the funds available to us.
Genome Canada will provide up to $250,000 over two years to projects relevant to genomics. For an application to be eligible to receive funding from Genome Canada the proposal must include genomics approaches as essential components in terms of importance to the overall outcomes of the project; or, address research into the implications of genomics in society from the perspective of the social sciences and humanities. Further information on the details of the funding can be found in the Funding Opportunity link above.
CIHR is using an expedited process for this review so as to have the outcomes of the research applied as quickly as possible. Applications are due on February 18, 2020 and the anticipated notice of decision by February 28, 2020. Please see the timeline in the funding opportunity.
CIHR will be the Lead Partner in this program and as such will be responsible for the management of the application and review process as described to the funding opportunity. Applications are not required to be submitted through the Regional Genome Centres. If you are interested, please see the link above to apply directly to CIHR.
If you have any questions, please contact Simon Potter at 204-230-7974 or by email at firstname.lastname@example.org.